Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Light therapy is effective and safe for treating skin color disorders like vitiligo and dark spots.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

The intestinal lymphatic system is active and promising for targeted drug delivery and therapies.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Laser treatment, especially when combined with other therapies, is effective for hair regrowth in alopecia areata.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

Higher IgE levels may play a role in alopecia areata, especially in males, children, and severe cases.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Chikungunya virus often causes skin issues and inflammation.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Combining narrow-band ultraviolet B light and stem cell transplantation helps repigmentation in vitiligo by maintaining calcium balance in mice.

Engineered cytokines show promise for improving tissue healing and safety in regenerative medicine.

γδ T cells are essential for wound healing after poxvirus infection.

Biological therapy boosts the immune system to effectively fight melanoma.

Certain drugs can change hair color, either lightening or darkening it.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.